Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Fujiwara, Hiroshi ^a,b   Ochi, Toshiki ^a   Yasukawa, Masaki ^a,b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 100; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; MELAN A; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 4; NY ESO 1 ANTIGEN; RETROVIRUS VECTOR; SMALL INTERFERING RNA; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; THYMIDINE KINASE; TUMOR ANTIGEN; WT1 PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CHRONIC MYELOID LEUKEMIA; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; GENE TRANSFER; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; MELANOMA; MEMORY T LYMPHOCYTE; REVIEW; SUICIDE GENE THERAPY; TUMOR SUPPRESSOR GENE; GENE THERAPY; GENETICS; IMMUNOLOGY; METHODOLOGY; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 77952537492     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/521248     Document Type: Review

References (67)

1. Rosenberg S. A., Dudley M. E., Adoptive cell therapy for the treatment of patients with metastatic melanoma Current Opinion in Immunology 2009 21 2 233 240
2. Johnson L. A., Morgan R. A., Dudley M. E., Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen Blood 2009 114 3 535 546
3. Morgan R. A., Dudley M. E., Wunderlich J. R., Cancer regression in patients after transfer of genetically engineered lymphocytes Science 2006 314 5796 126 129
4. Abad J. D., Wrzensinski C., Overwijk W., T-cell receptor gene therapy of established tumors in a murine melanoma model Journal of Immunotherapy 2008 31 1 1 6
5. De Witte M. A., Jorritsma A., Kaiser A., Requirements for effective antitumor responses of TCR transduced T cells Journal of Immunology 2008 181 7 5128 5136
6. Qazilbash M. H., Wieder E. D., Thall P. F., PR1 peptide vaccine-induced immune response is associated with better event-free survival in patients with myeloid leukemia Blood 2007 110 90a. abstract no. 283
7. Keilholz U., Letsch A., Busse A., A clinical and immunological phase II trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS Blood 2009 113 26 6541 6548
8. Xue S.-A., Gao L., Hart D., Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells Blood 2005 106 9 3062 3067
9. Mommaas B., van Halteren A. G. S., Pool J., Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer Haematologica 2005 90 10 1415 1421
10. Heemskerk M. H. M., Hoogeboom M., de Paus R. A., Redirection of antileukemic reactivity of peripheral T lymphocytes using genetransfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region Blood 2003 102 10 3530 3540
11. Tsuji T., Yasukawa M., Matsuzaki J., Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes Blood 2005 106 2 470 476
12. Weiden P. L., Flournoy N., Thomas E. D., Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts New England Journal of Medicine 1979 300 19 1068 1073
13. Weiden P. L., Sullivan K. M., Flournoy N., Storb R., Thomas E. D., Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation New England Journal of Medicine 1981 304 25 1529 1533
14. Michor F., Hughes T. P., Iwasa Y., Dynamics of chronic myeloid leukaemia Nature 2005 435 7046 1267 1270
15. Shah N. P., Skaggs B. J., Branford S., Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency Journal of Clinical Investigation 2007 117 9 2562 2569
16. Molldrem J. J., Lee P. P., Wang C., Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia Nature Medicine 2000 6 9 1018 1023
17. + T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation Blood 2003 102 8 2892 2900
18. Oka Y., Tsuboi A., Taguchi T., Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression Proceedings of the National Academy of Sciences of the United States of America 2004 101 38 13885 13890
19. Rosenberg S. A., Yang J. C., Restifo N. P., Cancer immunotherapy: moving beyond current vaccines Nature Medicine 2004 10 9 909 915
20. Dudley M. E., Wunderlich J. R., Robbins P. F., Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 2002 298 5594 850 854
21. + T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16168 16173
22. + T cells against NY-ESO-1 New England Journal of Medicine 2008 358 25 2698 2703
23. Marijt E., Wafelman A., van der Hoorn M., Phase I/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem cell transplantation Haematologica 2007 92 1 72 80
24. Kolb H.-J., Graft-versus-leukemia effects of transplantation and donor lymphocytes Blood 2008 112 12 4371 4383
25. Falkenburg J. H. F., Wafelman A. R., Joosten P., Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes Blood 1999 94 4 1201 1208
26. Xue S.-A., Gao L., Thomas S., Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice Haematologica 2010 95 1 126 134
27. Thomas S., Xue S.-A., Cesco-Gaspere M., Targeting the wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells Journal of Immunology 2007 179 9 5803 5810
28. Okamoto S., Mineno J., Ikeda H., Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR Cancer Research 2009 69 23 9003 9011
29. Heemskerk M. H. M., Hoogeboom M., Hagedoorn R., Kester M. G. D., Willemze R., Falkenburg J. H. F., Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer Journal of Experimental Medicine 2004 199 7 885 894
30. Dembic Z., Haas W., Weiss S., Transfer of specificity by murine and T-cell receptor genes Nature 1986 320 6059 232 238
31. Clay T. M., Custer M. C., Sachs J., Hwu P., Rosenberg S. A., Nishimura M. I., Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity Journal of Immunology 1999 163 1 507 513
32. Willemsen R. A., Weijtens M. E. M., Ronteltap C., Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR Gene Therapy 2000 7 16 1369 1377
33. + T cells Gene Therapy 2008 15 9 695 699
34. Morgan R. A., Dudley M. E., Yu Y. Y. L., High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens Journal of Immunology 2003 171 6 3287 3295
35. Zhao Y., Zheng Z., Robbins P. F., Khong H. T., Rosenberg S. A., Morgan R. A., Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines Journal of Immunology 2005 174 7 4415 4423
36. Date Y., Kimura A., Kato H., Sasazuki T., DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese Tissue Antigens 1996 47 2 93 101
37. Krausa P., Brywka M. III, Savage U., Genetic polymorphism within HLA-A 02: significant allelic variation revealed in different populations Tissue Antigens 1995 45 4 223 231
38. + cytotoxic T-lymphocyte clone specific for WT1 peptide Blood 2000 95 1 286 293
39. Yasukawa M., Fujiwara H., Ochi T., Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome American Journal of Hematology 2009 84 5 314 315
40. Duval L., Schmidt H., Kaltoft K., Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma Clinical Cancer Research 2006 12 4 1229 1236
41. Call M. E., Wucherpfennig K. W., The T cell receptor: critical role of the membrane environment in receptor assembly and function Annual Review of Immunology 2005 23 101 125
42. Heemskerk M. H. M., Hagedoorn R. S., van der Hoorn M. A. W. G., Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex Blood 2007 109 1 235 243
43. Cohen C. J., Zhao Y., Zheng Z., Rosenberg S. A., Morgan R. A., Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability Cancer Research 2006 66 17 8878 8886
44. Cohen C. J., Li Y. F., El-Gamil M., Robbins P. F., Rosenberg S. A., Morgan R. A., Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond Cancer Research 2007 67 8 3898 3903
45. Kuball J., Dossett M. L., Wolfl M., Facilitating matched pairing and expression of TCR chains introduced into human T cells Blood 2007 109 6 2331 2338
46. Sebestyen Z., Schooten E., Sals T., Human TCR that incorporate CD3 induce highly preferred pairing between TCR and chains following gene transfer Journal of Immunology 2008 180 11 7736 7746
47. Scholten K. B. J., Kramer D., Kueter E. W. M., Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells Clinical Immunology 2006 119 2 135 145
48. van der Veken L. T., Hagedoorn R. S., van Loenen M. M., Willemze R., Falkenburg J. H. F., Heemskerk M. H. M., T-cell receptor engineered T cells mediate effective antileukemic reactivity Cancer Research 2006 66 6 3331 3337
49. Hiasa A., Nishikawa H., Hirayama M., Rapid TCR-mediated responses in T cells transduced with cancer-specific TCR genes Gene Therapy 2009 16 5 620 628
50. Burns W. R., Zheng Z., Rosenberg S. A., Morgan R. A., Lack of specific-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation Blood 2009 114 14 2888 2899
51. Pule M. A., Savoldo B., Myers G. D., Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma Nature Medicine 2008 14 11 1264 1270
52. + T cells derived from central memory cells establishes persistent T cell memory in primates Journal of Clinical Investigation 2008 118 1 294 305
53. + T cells mediate superior antitumor immunity Proceedings of the National Academy of Sciences of the United States of America 2009 106 41 17469 17474
54. van Lent A. U., Nagasawa M., van Loenen M. M., Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors Journal of Immunology 2007 179 8 4959 4968
55. Zhao Y., Parkhurst M. R., Zheng Z., Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via notch signaling Cancer Research 2007 67 6 2425 2429
56. Bonini C., Ferrari G., Verzeletti S., HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 1997 276 5319 1719 1724
57. Ciceri F., Bonini C., Marktel S., Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation Blood 2007 109 11 4698 4707
58. Ciceri F., Bonini C., Stanghellini M. T. L., Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study The Lancet Oncology 2009 10 5 489 500
59. Recchia A., Bonini C., Magnani Z., Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells Proceedings of the National Academy of Sciences of the United States of America 2006 103 5 1457 1462
60. Cartier N., Hacein-Bey-Abina S., Bartholomae C. C., Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy Science 2009 326 5954 818 823
61. Aiuti A., Cattaneo F., Galimberti S., Gene therapy for immunodeficiency due to adenosine deaminase deficiency New England Journal of Medicine 2009 360 5 447 458
62. + peripheral blood progenitor cells in the treatment of AIDS related lymphoma (ARL) Blood 2008 112 818a. abstract no. 2348
63. + T cells expressing a known endogenous TCR Molecular Therapy 2009 17 4 742 749
64. Ochi T., Fujiwara H., Yasukawa M., Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia Expert Opinion on Therapeutic Targets 2009 13 12 1399 1410
65. Ochi T., Fujiwara H., Suemori K., Aurora-A kinase: a novel target of cellular immunotherapy for leukemia Blood 2009 113 1 66 74
66. Nagai K., Fujiwara H., Ochi T., Development of a novel anti-leukemia gene immunotherapy using Aurora-A kinase-specific T-cell receptor gene transfer Blood 2009 114 158a. abstract no. 375
67. Arai J., Yasukawa M., Ohminami H., Kakimoto M., Hasegawa A., Fujita S., Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes Blood 2001 97 9 2903 2907